(Re)Vitalizing Pulmonary Rehabilitation for Patients With Chronic Respiratory Diseases
3R
1 other identifier
interventional
146
1 country
1
Brief Summary
3R aims to increase the access of patients with chronic respiratory diseases (CRD) to pulmonary rehabilitation (PR) in Portugal. The main goals of 3R are: i) design and implement an innovative community-based PR programme; ii) assess the cost-benefit of the community-based PR programme; iii) disseminate and perform knowledge transfer about PR across the country. PR is an evidence-based intervention for the management of CRD and offering PR has been defined as a priority by national/international organizations. However, in Portugal PR is practically inexistent (\<1% of "candidate" patients have access). Currently, PR programmes are hospital-based and directed to patients with advanced disease. One of the recommendations to enhance the implementation of PR is the development on novel models of programme delivery. It is hypothesised that community-based programs, direct to patients at all grades of the disease, and involving all stakeholders (health professionals, patients, society, policy makers) may turn PR more accessible. The plan is to implement community-based PR programs in 4 primary care centres of 2 ACES of the centre region of Portugal and assess the impact of such intervention in several domains using surrogate and patient-/family-centered outcomes. A cost-benefit analysis will be performed on acute exacerbations and healthcare utilization. Dissemination will include one conference, activities with the community, courses and an online PR toolkit. Four schools of 2 polytechnics, 2 city councils, the Health Regional Administration-Centre (ARS-Centro) and all respiratory professional and civic national associations are partners.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 14, 2018
CompletedStudy Start
First participant enrolled
January 7, 2019
CompletedFirst Posted
Study publicly available on registry
January 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedJuly 8, 2020
July 1, 2020
12 months
December 14, 2018
July 7, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Health Related quality-of-life: St. George Respiratory Questionnaire
St. George Respiratory Questionnaire (SGRQ) will be used to assess Health Related quality-of-life. The SGRQ is a comprehensive well-established 50-item questionnaire to measure health status in patients with chronic respiratory diseases. Scores can be provided for each domain and as a total score, ranging from 0 (no impairment) to 100 (worst possible health status).
Up to 9 months
Secondary Outcomes (23)
Change in airflow obstruction
Up to 9 months
Change in exercise capacity
Up to 9 months
Change in functionality
Up to 9 months
Change in quadriceps muscle strength
Up to 9 months
Change in biceps muscle strength
Up to 3 months
- +18 more secondary outcomes
Other Outcomes (1)
Change in Body Mass Index
Up to 9 months
Study Arms (2)
Pulmonary Rehabilitation Group
EXPERIMENTALPatients will participate in a 12-week community-based pulmonary rehabilitation programme.
Standard Care Group
ACTIVE COMPARATORPatients will continue to receive the standard care, which means the daily medication prescribed by the pshysician from the primary care centre team.
Interventions
Patients will be treated with daily medication prescribed by the physician. Additionally patients will participate in a 12-w.eek community-based pulmonary rehabilitation programme, with two exercise training sessions per week and six psycho-education sessions, managed by a multidisciplinary team, once every two weeks. Patient's families will be invited to participate in the psychoeducational component
Patients will be treated with daily medication prescribed by the physician and will continue to receive the standard care from the primary care centre team.
Eligibility Criteria
You may qualify if:
- clinical diagnosis of a chronic respiratory disease
- clinically stable in the previous month
- ≥ 18 years old
- able to provide their own informed consent
You may not qualify if:
- cognitive impairments
- inability to understand and co-operate
- history of neoplasic /immunologic disease or acute cardiac condition or a significant cardiac, musculoskeletal, neuromuscular or psychiatric condition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aveiro Universitylead
- Fundação para a Ciência e a Tecnologiacollaborator
Study Sites (1)
University of Aveiro
Aveiro, 3810-193, Portugal
Related Publications (3)
Paixao C, Rebelo P, Oliveira A, Jacome C, Cruz J, Martins V, Simao P, Marques A. Responsiveness and Minimal Clinically Important Difference of the Brief-BESTest in People With COPD After Pulmonary Rehabilitation. Phys Ther. 2021 Nov 1;101(11):pzab209. doi: 10.1093/ptj/pzab209.
PMID: 34499161DERIVEDRebelo P, Oliveira A, Andrade L, Valente C, Marques A. Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Fatigue in Patients With COPD Following Pulmonary Rehabilitation. Chest. 2020 Aug;158(2):550-561. doi: 10.1016/j.chest.2020.02.045. Epub 2020 Mar 14.
PMID: 32184112DERIVEDMarques A, Jacome C, Rebelo P, Paixao C, Oliveira A, Cruz J, Freitas C, Rua M, Loureiro H, Peguinho C, Marques F, Simoes A, Santos M, Martins P, Andre A, De Francesco S, Martins V, Brooks D, Simao P. Improving access to community-based pulmonary rehabilitation: 3R protocol for real-world settings with cost-benefit analysis. BMC Public Health. 2019 May 31;19(1):676. doi: 10.1186/s12889-019-7045-1.
PMID: 31151409DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Alda S. Marques, PhD
School of Health Sciences of the University of Aveiro (ESSUA)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Lecturer
Study Record Dates
First Submitted
December 14, 2018
First Posted
January 10, 2019
Study Start
January 7, 2019
Primary Completion
December 30, 2019
Study Completion
June 30, 2020
Last Updated
July 8, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share